Quercetin intake during lactation modulates the AMP-activated protein kinase pathway in the livers of adult male rat offspring programmed by maternal protein restriction

Journal of Nutritional Biochemistry

Volumn 24, Issue 1, 2013, Pages 118-123

  Sato, Shin ^a   Mukai, Yuuka ^a   Saito, Takeshi ^b  

^a AOMORI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

AMP activated protein kinase pathway; Endothelial nitric oxide synthase; Liver; Maternal protein restriction; Quercetin

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOSINE 5' MONOPHOSPHATE ACTIVATED PROTEIN KINASE; ADENOSINE PHOSPHATE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE; QUERCETIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; LACTATION; MALE; NONHUMAN; PROGENY; PROTEIN PHOSPHORYLATION; PROTEIN RESTRICTION; RAT;

ACETYL-COA CARBOXYLASE; AGE FACTORS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BODY WEIGHT; DIET, PROTEIN-RESTRICTED; FEMALE; LACTATION; LIVER; MALE; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; ORGAN SIZE; PHOSPHORYLATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; QUERCETIN; RATS; RATS, WISTAR; TOR SERINE-THREONINE KINASES;

MAMMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84870450728     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.03.007     Document Type: Article

References (39)

1. Barker D.J., Bagby S.P., Hanson M.A. Mechanisms of disease: in utero programming in the pathogenesis of hypertension. Nat Clin Pract 2006, 2:700-707.
2. Curhan G.C., Willett W.C., Rimm E.B., et al. Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 1996, 94:3246-3250.
3. McMullen S., Langley-Evans S.C. Maternal low-protein diet in rat pregnancy programs blood pressure through sex-specific mechanisms. Am J Physiol Regul Integr Comp Physiol 2005, 288:R85-R90.
4. Warner M.J., Ozanne S.E. Mechanisms involved in the developmental programming of adulthood disease. Biochem J 2010, 427:333-347.
5. Hardie D.G., Pan D.A. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 2002, 30:1064-1070.
6. Saha A.K., Ruderman N.B. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem 2003, 253:65-70.
7. Zhang Y., Lee T.S., Kolb E.M., et al. AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 2006, 26:1281-1287.
8. Chen Z., Peng I.C., Sun W., et al. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res 2009, 104:496-505.
9. Bauer C., Walcher F., Kalweit U., et al. Role of nitric oxide in the regulation of the hepatic microcirculation in vivo. J Hepatol 1997, 27:1089-1095.
10. Schoen J.M., Wang H.H., Minuk G.Y., et al. Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 2001, 5:453-464.
11. García-Trevijano E.R., Martínez-Chantar M.L., Latasa M.U., et al. NO sensitizes rat hepatocytes to proliferation by modifying S-adenosylmethionine levels. Gastroenterology 2002, 122:1355-1363.
12. Ahn J., Lee H., Kim S., et al. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 2008, 373:545-549.
13. Lee Y.K., Park S.Y., Kim Y.M., et al. AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Exp Mol Med 2009, 41:201-207.
14. Lu J., Wu D.M., Zheng Y.L., et al. Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol 2010, 222:199-212.
15. Jung J.H., Lee J.O., Kim J.H., et al. Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation. J Cell Physiol 2010, 223:408-414.
16. Khoo N.K., White C.R., Pozzo-Miller L., et al. Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med 2010, 49:339-347.
17. Sánchez M., Galisteo M., Vera R., et al. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006, 24:75-84.
18. Wlodek M.E., Mibus A., Tan A., et al. Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat. J Am Soc Nephrol 2007, 18:1688-1696.
19. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., et al. A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007, 45:2179-2205.
20. Stoewsand G.S., Anderson J.L., Boyd J.N., et al. Quercetin: a mutagen, not a carcinogen, in Fischer rats. J Toxicol Environ Health 1984, 14:105-114.
21. Ha J., Daniel S., Broyles S.S., et al. Critical phosphorylation sites for acetyl-CoA carboxylase activity. J Biol Chem 1994, 269:22162-22168.
22. Calvert J.W., Gundewar S., Jha S., et al. Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes 2008, 57:696-705.
23. Chotechuang N., Azzout-Marniche D., Bos C., et al. mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat. Am J Physiol Endocrinol Metab 2009, 297:E1313-E1323.
24. Towler M.C., Hardie D.G. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007, 100:328-341.
25. Hwang J.T., Kwon D.Y., Yoon S.H. AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol 2009, 26:17-22.
26. Reiter C.E., Kim J.A., Quon M.J. Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology 2010, 151:103-114.
27. Suchankova G., Nelson L.E., Gerhart-Hines Z., et al. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009, 378:836-841.
28. Franco Mdo C., Arruda R.M., Dantas A.P., et al. Intrauterine undernutrition: expression and activity of the endothelial nitric oxide synthase in male and female adult offspring. Cardiovasc Res 2002, 56:145-153.
29. Brawley L., Itoh S., Torrens C., et al. Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring. Pediatr Res 2003, 54:83-90.
30. Alexander B.T. Fetal programming of hypertension. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1-R10.
31. Sato S., Mukai Y., Norikura T. Maternal low-protein diet suppresses vascular and renal endothelial nitric oxide synthase phosphorylation in rat offspring independent of a postnatal fructose diet. J Dev Orig Health Dis 2011, 2:168-175.
32. Kahn B.B., Alquier T., Carling D., et al. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005, 1:15-25.
33. Vázquez-Chantada M., Ariz U., Varela-Rey M., et al. Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation. Hepatology 2009, 49:608-617.
34. Davis B.J., Xie Z., Viollet B., et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006, 55:496-505.
35. Merezak S., Reusens B., Renard A., et al. Effect of maternal low-protein diet and taurine on the vulnerability of adult Wistar rat islets to cytokines. Diabetologia 2004, 47:669-675.
36. Goosse K., Bouckenooghe T., Balteau M., et al. Implication of nitric oxide in the increased islet-cells vulnerability of adult progeny from protein-restricted mothers and its prevention by taurine. J Endocrinol 2009, 200:177-187.
37. Theys N., Clippe A., Bouckenooghe T., et al. Early low protein diet aggravates unbalance between antioxidant enzymes leading to islet dysfunction. PLoS One 2009, 4:e6110.
38. Coskun O., Kanter M., Korkmaz A., et al. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res 2005, 51:117-123.
39. Youl E., Bardy G., Magous R., et al. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol 2010, 161:799-814.